CARE Corona accelerated R&D in Europe

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $42,384,953.31
  • Funder

    EC (IMI)
  • Principle Investigator

    Pending
  • Research Location

    France, Europe
  • Lead Research Institution

    Institut National de la Santé et de la Recherche Médicale (INSERM)
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    Gender

  • Study Subject

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

To identify candidates among existing drugs that could be effective as treatments (drug repurposing), and develop new drugs specially designed to tackle the SARS-CoV2 virus, in order to deliver treatments for the current outbreak, as well as future coronavirus outbreaks.